Common Stock, Shares, Outstanding of Design Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Design Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2025.
  • Design Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2025 was 57M shares, a 0.61% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)

Design Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 57M +343K +0.61% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 56.9M +328K +0.58% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 56.8M +274K +0.49% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 56.8M +281K +0.5% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 56.6M +623K +1.11% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 56.6M +641K +1.15% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 56.5M +575K +1.03% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 56.5M +578K +1.03% Dec 31, 2023 10-K 2025-03-10
Q3 2023 56M +157K +0.28% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 56M +262K +0.47% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 55.9M +301K +0.54% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 55.9M +454K +0.82% Dec 31, 2022 10-K 2024-03-19
Q3 2022 55.8M +616K +1.12% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 55.7M +602K +1.09% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 55.6M +576K +1.05% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 55.4M +39.5M +247% Dec 31, 2021 10-K 2023-03-14
Q3 2021 55.2M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 55.1M Jun 30, 2021 10-Q 2021-08-09
Q1 2021 55M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 16M Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.